Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series.
The largest kindred with inherited prion disease P102L, historically Gerstmann-Sträussler-Scheinker syndrome, originates from central England, with émigrés now resident in various parts of the English-speaking world. We have collected data from 84 patients in the large UK kindred and numerous small...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2008
|
| _version_ | 1797083921373986816 |
|---|---|
| author | Webb, T Poulter, M Beck, J Uphill, J Adamson, G Campbell, T Linehan, J Powell, C Brandner, S Pal, S Siddique, D Wadsworth, J Joiner, S Alner, K Petersen, C Hampson, S Rhymes, C Treacy, C Storey, E Geschwind, MD Nemeth, A Wroe, S Collinge, J Mead, S |
| author_facet | Webb, T Poulter, M Beck, J Uphill, J Adamson, G Campbell, T Linehan, J Powell, C Brandner, S Pal, S Siddique, D Wadsworth, J Joiner, S Alner, K Petersen, C Hampson, S Rhymes, C Treacy, C Storey, E Geschwind, MD Nemeth, A Wroe, S Collinge, J Mead, S |
| author_sort | Webb, T |
| collection | OXFORD |
| description | The largest kindred with inherited prion disease P102L, historically Gerstmann-Sträussler-Scheinker syndrome, originates from central England, with émigrés now resident in various parts of the English-speaking world. We have collected data from 84 patients in the large UK kindred and numerous small unrelated pedigrees to investigate phenotypic heterogeneity and modifying factors. This collection represents by far the largest series of P102L patients so far reported. Microsatellite and genealogical analyses of eight separate European kindreds support multiple distinct mutational events at a cytosine-phosphate diester-guanidine dinucleotide mutation hot spot. All of the smaller P102L kindreds were linked to polymorphic human prion protein gene codon 129M and were not connected by genealogy or microsatellite haplotype background to the large kindred or each other. While many present with classical Gerstmann-Sträussler-Scheinker syndrome, a slowly progressive cerebellar ataxia with later onset cognitive impairment, there is remarkable heterogeneity. A subset of patients present with prominent cognitive and psychiatric features and some have met diagnostic criteria for sporadic Creutzfeldt-Jakob disease. We show that polymorphic human prion protein gene codon 129 modifies age at onset: the earliest eight clinical onsets were all MM homozygotes and overall age at onset was 7 years earlier for MM compared with MV heterozygotes (P = 0.02). Unexpectedly, apolipoprotein E4 carriers have a delayed age of onset by 10 years (P = 0.02). We found a preponderance of female patients compared with males (54 females versus 30 males, P = 0.01), which probably relates to ascertainment bias. However, these modifiers had no impact on a semi-quantitative pathological phenotype in 10 autopsied patients. These data allow an appreciation of the range of clinical phenotype, modern imaging and molecular investigation and should inform genetic counselling of at-risk individuals, with the identification of two genetic modifiers. |
| first_indexed | 2024-03-07T01:48:22Z |
| format | Journal article |
| id | oxford-uuid:9935fd0b-d396-407e-a346-aabca5784361 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:48:22Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:9935fd0b-d396-407e-a346-aabca57843612022-03-27T00:12:46ZPhenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9935fd0b-d396-407e-a346-aabca5784361EnglishSymplectic Elements at Oxford2008Webb, TPoulter, MBeck, JUphill, JAdamson, GCampbell, TLinehan, JPowell, CBrandner, SPal, SSiddique, DWadsworth, JJoiner, SAlner, KPetersen, CHampson, SRhymes, CTreacy, CStorey, EGeschwind, MDNemeth, AWroe, SCollinge, JMead, SThe largest kindred with inherited prion disease P102L, historically Gerstmann-Sträussler-Scheinker syndrome, originates from central England, with émigrés now resident in various parts of the English-speaking world. We have collected data from 84 patients in the large UK kindred and numerous small unrelated pedigrees to investigate phenotypic heterogeneity and modifying factors. This collection represents by far the largest series of P102L patients so far reported. Microsatellite and genealogical analyses of eight separate European kindreds support multiple distinct mutational events at a cytosine-phosphate diester-guanidine dinucleotide mutation hot spot. All of the smaller P102L kindreds were linked to polymorphic human prion protein gene codon 129M and were not connected by genealogy or microsatellite haplotype background to the large kindred or each other. While many present with classical Gerstmann-Sträussler-Scheinker syndrome, a slowly progressive cerebellar ataxia with later onset cognitive impairment, there is remarkable heterogeneity. A subset of patients present with prominent cognitive and psychiatric features and some have met diagnostic criteria for sporadic Creutzfeldt-Jakob disease. We show that polymorphic human prion protein gene codon 129 modifies age at onset: the earliest eight clinical onsets were all MM homozygotes and overall age at onset was 7 years earlier for MM compared with MV heterozygotes (P = 0.02). Unexpectedly, apolipoprotein E4 carriers have a delayed age of onset by 10 years (P = 0.02). We found a preponderance of female patients compared with males (54 females versus 30 males, P = 0.01), which probably relates to ascertainment bias. However, these modifiers had no impact on a semi-quantitative pathological phenotype in 10 autopsied patients. These data allow an appreciation of the range of clinical phenotype, modern imaging and molecular investigation and should inform genetic counselling of at-risk individuals, with the identification of two genetic modifiers. |
| spellingShingle | Webb, T Poulter, M Beck, J Uphill, J Adamson, G Campbell, T Linehan, J Powell, C Brandner, S Pal, S Siddique, D Wadsworth, J Joiner, S Alner, K Petersen, C Hampson, S Rhymes, C Treacy, C Storey, E Geschwind, MD Nemeth, A Wroe, S Collinge, J Mead, S Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. |
| title | Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. |
| title_full | Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. |
| title_fullStr | Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. |
| title_full_unstemmed | Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. |
| title_short | Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. |
| title_sort | phenotypic heterogeneity and genetic modification of p102l inherited prion disease in an international series |
| work_keys_str_mv | AT webbt phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT poulterm phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT beckj phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT uphillj phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT adamsong phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT campbellt phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT linehanj phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT powellc phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT brandners phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT pals phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT siddiqued phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT wadsworthj phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT joiners phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT alnerk phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT petersenc phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT hampsons phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT rhymesc phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT treacyc phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT storeye phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT geschwindmd phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT nemetha phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT wroes phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT collingej phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries AT meads phenotypicheterogeneityandgeneticmodificationofp102linheritedpriondiseaseinaninternationalseries |